Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Oncology Informatics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Oncology Informatics Market 23
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Oncology Informatics Market 26
Figure 9. Investment Opportunity Analysis 30
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Oncology Informatics Market 33
Figure 11. Breakdown of Asia Pacific Oncology Informatics Market by Product Type, 2019-2030, % of Revenue 38
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 38
Figure 13. Asia Pacific Oncology Informatics Market: Electronic Health Records (EHRs), 2019-2030, $ mn 39
Figure 14. Asia Pacific Oncology Informatics Market: Population Health Management (PHM), 2019-2030, $ mn 41
Figure 15. Asia Pacific Oncology Informatics Market: Clinical Decision Support System (CDSS), 2019-2030, $ mn 43
Figure 16. Asia Pacific Oncology Informatics Market: Drug Discovery and Development Informatics (DDDI), 2019-2030, $ mn 45
Figure 17. Asia Pacific Oncology Informatics Market: Data Analytics, 2019-2030, $ mn 47
Figure 18. Asia Pacific Oncology Informatics Market: Image Analytics, 2019-2030, $ mn 48
Figure 19. Asia Pacific Oncology Informatics Market: Other Product Types, 2019-2030, $ mn 49
Figure 20. Breakdown of Asia Pacific Oncology Informatics Market by Cancer Type, 2019-2030, % of Sales Revenue 50
Figure 21. Asia Pacific Addressable Market Cap in 2020-2030 by Cancer Type, Value ($ mn) and Share (%) 51
Figure 22. Asia Pacific Oncology Informatics Market: Colorectal Cancer, 2019-2030, $ mn 52
Figure 23. Asia Pacific Oncology Informatics Market: Breast Cancer, 2019-2030, $ mn 53
Figure 24. Asia Pacific Oncology Informatics Market: Prostate Cancer, 2019-2030, $ mn 54
Figure 25. Asia Pacific Oncology Informatics Market: Cervical Cancer, 2019-2030, $ mn 55
Figure 26. Breakdown of Asia Pacific Oncology Informatics Market by Application, 2019-2030, % of Sales Revenue 56
Figure 27. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 57
Figure 28. Asia Pacific Oncology Informatics Market: Medical Application, 2019-2030, $ mn 58
Figure 29. Asia Pacific Oncology Informatics Market: Surgical Application, 2019-2030, $ mn 59
Figure 30. Asia Pacific Oncology Informatics Market: Radiation Application, 2019-2030, $ mn 60
Figure 31. Breakdown of Asia Pacific Oncology Informatics Market by End User, 2019-2030, % of Revenue 62
Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 63
Figure 33. Asia Pacific Oncology Informatics Market: Pharmaceutical Companies, 2019-2030, $ mn 64
Figure 34. Asia Pacific Oncology Informatics Market: Life Science Companies, 2019-2030, $ mn 65
Figure 35. Asia Pacific Oncology Informatics Market: Contract Research Organizations (CROs), 2019-2030, $ mn 66
Figure 36. Asia Pacific Oncology Informatics Market: Academic Institutes and Research Centers, 2019-2030, $ mn 67
Figure 37. Asia Pacific Oncology Informatics Market: Other End Users, 2019-2030, $ mn 68
Figure 38. Breakdown of APAC Oncology Informatics Market by Country, 2019 and 2030, % of Revenue 70
Figure 39. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 71
Figure 40. Oncology Informatics Market in Japan, 2019-2030, $ mn 73
Figure 41. Oncology Informatics Market in China, 2019-2030, $ mn 75
Figure 42. Oncology Informatics Market in Australia, 2019-2030, $ mn 77
Figure 43. Oncology Informatics Market in India, 2019-2030, $ mn 79
Figure 44. Oncology Informatics Market in South Korea, 2019-2030, $ mn 81
Figure 45. Oncology Informatics Market in Rest of APAC, 2019-2030, $ mn 83
Figure 46. Growth Stage of Asia Pacific Oncology Informatics Industry over the Forecast Period 85
Asia Pacific oncology informatics market will grow by 7.8% annually with a total addressable market cap of $16.75 billion over 2020-2030 owing to the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates. Highlighted with 34 tables and 46 figures, this 113-page report “Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country. Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Electronic Health Records (EHRs) • Population Health Management (PHM) • Clinical Decision Support System (CDSS) • Drug Discovery and Development Informatics (DDDI) • Data Analytics • Image Analytics • Other Product Types Based on Cancer Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Colorectal Cancer • Breast Cancer • Prostate Cancer • Cervical Cancer • Other Cancers Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Medical Application • Surgical Application • Radiation Application Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Life Science Companies • Contract Research Organizations (CROs) • Academic Institutes and Research Centers • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Cerner Corporation Change Healthcare Elekta AB F.Hoffmann-La Roche Ltd. Hologic Inc. IBM Corporation Inspirata Inc. Koninklijke Philips N.V. Laboratory Corporation of America Holdings McKesson Corporation MIM Software, Inc. Oncology Analytics, Inc PerkinElmer, Inc. RELX Group Sirenas, LLC UnitedHealth Group, Inc Varian Medical Systems, Inc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More